Trials / Completed
CompletedNCT02069665
Effectiveness Study of Integrative Treatment for Pediatric Pneumonia
Assessing the Effectiveness of Integrative Treatment That Combines Interior and Exterior Treatment Plans in Pediatric Pneumonia: a Program by PRC National Clinical Research Base of Traditional Chinese Medicine for Major Diseases
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 451 (actual)
- Sponsor
- Liaoning University of Traditional Chinese Medicine · Academic / Other
- Sex
- All
- Age
- 6 Months – 59 Months
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effectiveness of traditional Chinese medicine for treatment of pediatric pneumonia. It is a multicenter randomized controlled trial.
Detailed description
The retrospective case study has been finished at the National clinical research base of traditional Chinese medicine for major disease pediatric pneumonia, and the research center organized the field training of prospective-study to coordinated units. Based on the primary statistical outcomes of retrospective case study and the discussion around prospective-study during the training, investigators found it difficult to include simplex viral infection, therefore, investigators revised the inclusion criteria and treatment protocol of the pragmatic randomized controlled trial. The block randomization is used in this trial. Random numbers are generated by SPSS software. Statistical analysis staff and those who perform the follow-up are blinded. Sample size calculation was performed, which was 369, and considering drop-out or withdrawal, investigators plan to enroll 450 patients (300 in experimental group, 150 in control).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Fuxiong San | external application; 8-10cm wide, 0.3-0.5cm thick; 10mins for patient aged 1 to 3-year old; 15mins for those aged 3 to 5-year old; once daily |
| DRUG | Xiyanping injection | ivd. 5 to 10 mg/(kg•d), plus 5% Glucose Injection, 80 to 100 ml, ivd. Once a day injection. |
| DRUG | Ribavirin Injection | ivd. 10 to 20 mg/(kg•d), plus 5% Glucose Injection, 80 to 100 ml, ivd. Once a day injection. |
| DRUG | Xiaoer Qingfei Heji (mixture) | children aged 6 months to 1 year old: 10 ml, orally taken three times daily; children aged 1 to 3 year old: 15 ml, orally taken three times daily; children aged 3 to 5 year old: 20 ml, orally taken three times daily; |
| DRUG | Zhi Ke San | children aged 6 months to 1 year old: 0.5g, orally taken three times daily; children aged 1 to 3 year old: 1.5g, orally taken three times daily; children aged 3 to 5 year old: 2.0g, orally taken three times daily; |
| DRUG | Hua Tan San | children aged 6 months to 1 year old: 0.5g, orally taken three times daily; children aged 1 to 3 year old: 1.5g, orally taken three times daily; children aged 3 to 5 year old: 2.0g, orally taken three times daily; |
| DRUG | Guaifenesin Syrup | children aged 6 months to 1 year old: 3ml, orally taken three times daily; children aged 1 to 3 year old: 5ml, orally taken three times daily; children aged 3 to 5 year old: 8ml, orally taken three times daily; |
| DRUG | Ibuprofen Suspension | taken under prescription |
| DRUG | salbutamol | taken under prescription |
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2013-07-01
- Completion
- 2013-08-01
- First posted
- 2014-02-24
- Last updated
- 2014-02-24
Locations
6 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02069665. Inclusion in this directory is not an endorsement.